arrow
R

Ron T. Gansevoort

University Medical Centre Groningen, University of Groningen
H指数:117
被引数:7.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC)

2026年ESC心血管疾病与慢性肾脏病管理指南,与欧洲肾脏协会(ERA)合作制定:由欧洲心脏病学会(ESC)心血管疾病与慢性肾脏病管理工作组制定

2026-08-280
OAAI
Efficacy and safety of the cystic fibrosis transmembrane conductance regulator inhibitor GLPG2737 for autosomal dominant polycystic kidney disease: phase 2a MANGROVE study

囊性纤维化跨膜电导调节器抑制剂GLPG2737在常染色体显性多囊肾病中的疗效与安全性:MANGROVE 2a期研究

2026-05-270
OA
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals

在640万个人中预防和评分2心血管风险方程的跨国验证

2026-05-050
OAAI
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria – Proteinuria Workshop

关于优化评估尿微量白蛋白和蛋白尿的尿液样本前处理建议——美国肾脏基金会尿微量白蛋白-蛋白尿研讨会的共识报告

2026-04-240
OA
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial
2025-04-010
PRE
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease

瑞奈生命周期试验的原理与设计:评估达格列净对严重慢性肾病心血管肾脏结局的影响

2025-03-070
PRE